Following the announcements in October 2023 and January 2024 of accelerated construction and development planning by portfolio company CDC, CDC has now entered into over 110MW of new customer contracts to support this capacity growth and underwrite further development.
These contracts, which are from new and existing customers across Australia and New Zealand, will be delivered through expansion of CDC’s existing data centre footprints, as well as from development of new facilities, all of which have commenced construction.
The customer contracts have a phased delivery schedule over the next 3 years. When delivered, they will also extend the Company’s weighted average lease expiry, including options to extend.
Combined with the additional contracts secured throughout the last 12 months, CDC’s total contracted capacity has increased by over 200MW over the last 12 months, including reservations and rights of first offer. Over the same period, CDC has announced that it had commenced construction of a further 265MW of capacity, and significantly extended its future build capacity beyond that.
Infratil’s CEO Jason Boyes said: “It is pleasing to announce the conversion of advanced customer conversations into contracted capacity in line with the accelerated growth expectations we announced in October 2023 and January 2024. This progress has been reflected in the material increase in the independent valuation of CDC over the course of this financial year and reinforces our confidence in CDC’s future growth prospects.”
Enquiries should be directed to:
Matthew Ross
Deputy CFO
Email: matthew.ross@infratil.com
Related
Australian data centre update
Infratil Limited (NZX/ASX:IFT) notes it has recently received a number of investor queries regarding power delivery timelines for under-construction sites in Australia. CDC has confirmed that it has robust delivery
Infratil Newsletter - October 2026
Attached is a copy of the latest Infratil Newsletter for investors, with commentary on our recent Investor Day and developments at various portfolio companies. Enquiries should be directed to: Brett
CDC Independent Valuation – 30 September 2026
CDC Independent Valuation – 30 September 2026 CDC’s independent valuation was broadly flat with a mid-point valuation of A$18.5 billion at 30 September 2026. Continued progress in customer contracting and